Dow Up 0.08% Nasdaq Down 0.30%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
1.00 Up 0.08(8.62%) Sep 19, 4:00PM EDT
|After Hours : 0.99 Down 0.01 (1.00%) Sep 19, 4:53PM EDT
Prev Close:0.92
Open:0.92
Bid:0.93 x 300
Ask:1.01 x 4000
1y Target Est:3.50
Beta:1.07
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:0.89 - 1.00
52wk Range:0.65 - 4.00
Volume:580,884
Avg Vol (3m):409,328
Market Cap:60.66M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCUp 8.62%60.66M
AGENDown 2.01%183.02M
DNDNUp 5.63%233.14M
STMLDown 5.47%165.58M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback